Clenbuterol vs Semax
Well Studied vs Well Studied
monitor Mechanism-based · 51% Both Clenbuterol and Semax can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar).
Molecular Data
Clenbuterol Semax
Weight 277.19 Da 813.93 Da
Half-life ~36 hours 0.5-2 hours
Chain — 7 amino acids
Type Sympathomimetic amine (C12H18Cl2N2O) ACTH(4-10) synthetic analog
Key Benefits
Clenbuterol
01 Increased basal metabolic rate and thermogenesis for accelerated fat loss
02 Preferential mobilization of stored body fat through enhanced lipolysis
03 Anti-catabolic effects that help preserve lean muscle mass during caloric restriction
04 Bronchodilation and improved respiratory capacity during intense exercise
05 Appetite suppression in many users, supporting adherence to caloric deficit
06 Oral administration with no injections required
Semax
01 Rapid brain delivery via intranasal route
02 Rapidly increases BDNF levels
03 Extensive clinical research in Russia
04 Easy self-administration
05 Modulates dopamine and serotonin systems
06 Neuroprotective effects
Dosing Protocols
Clenbuterol
20-120 mcg/day / Once daily (morning)
Semax
300-600mcg per dose (up to 1000mcg for intensive use) / 1-2x daily (morning recommended for cognitive boost)
Research protocol 500-750mcg 1x daily
Intensive protocol 750-1000mcg 1-2x daily
Side Effects
Clenbuterol
Tremors and shaking (especially hands) - most pronounced in the first 3-5 days
Tachycardia (elevated heart rate, typically 10-20 bpm above baseline)
Insomnia and sleep disturbance, particularly with afternoon or evening dosing
Muscle cramps (calves, forearms, back) due to taurine depletion
Increased sweating and elevated body temperature
Headaches, particularly during dose ramp-up
Nervousness, anxiety, and restlessness
Increased blood pressure
Semax
Mild nasal discomfort (nasal route)
Possible nasal sensation upon administration
Contraindications
Pre-existing cardiovascular disease, cardiomyopathy, or arrhythmia
Uncontrolled hypertension
Hyperthyroidism or thyrotoxicosis
Hypokalemia or electrolyte imbalances
Known hypersensitivity to clenbuterol or sympathomimetic amines
Concurrent use of other stimulants (ephedrine, amphetamines) or MAO inhibitors
Pregnancy or breastfeeding
Pregnancy or breastfeeding
Known peptide allergies
Do not exceed 4-week continuous use without medical supervision
Research Evidence
Clenbuterol Semax
Status Well Studied Well Studied
References 5 studies 5 studies
Latest 2021 2025
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.